LifeArc logo
LifeArc Gene Therapy Innovation Fund

LifeArc Gene Therapy Innovation Fund

Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.

ClosedLifeArcUnited Kingdom
View on funder site
About

LifeArc administers the Gene Therapy Innovation Fund as a grant fund for promising gene therapies for people living with rare conditions. GTIF is a GBP 5 million annual fund, and the funding panel reviews full applications and makes funding decisions twice a year.

LifeArc does not publish per-project award minimums, per-project caps, a current deadline, an application URL, or a scoring rubric. Th…

What this grant funds

Rare-condition gene therapy projects, including viral-vector manufacturing and translational work needed to advance promising therapies.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.£5M
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Where founders trip up

Sign up free to see where teams trip up

Create free accountSign in
Last verified: 24 Jul 2026Source: www.lifearc.org